OverviewChartNewsTraderScreen

CV Sciences, Inc./  US1266541028  /

Nasdaq Other OTC
2024-07-31  9:46:33 PM Chg. -0.0003 Volume Bid- Ask- High Low
0.0518USD -0.48% 537,039
Turnover: 27,316.1065		 -Bid Size: - -Ask Size: - 0.0520 0.0485
GlobeNewswire 2022-03-28 CV Sciences, Inc. to Announce Fourth Quarter and Full Year 2021 Results on March 31, 2022
GlobeNewswire 2022-03-11 UPDATE -- CV Sciences Adds +PlusCBD Relief Softgels to Wellness Line of CBD Products
GlobeNewswire 2022-03-08 CV Sciences Adds +PlusCBD Relief Softgels to Wellness Line of CBD Products
GlobeNewswire 2022-01-24 Cannabis Industry Investor Presentations Now Available for On-Demand Viewing
GlobeNewswire 2022-01-18 Cannabis Industry Investor Conference: Company Executives Present January 19th & 20th
GlobeNewswire 2022-01-11 CV Sciences, Inc. Announces Launch of +PlusCBD™ Pain Relief Topicals
GlobeNewswire 2022-01-05 CV Sciences, Inc. Announces New Distribution Agreement with GNC
GlobeNewswire 2021-11-30 CV Sciences, Inc. Appoints Haskell & White LLP as Auditor
GlobeNewswire 2021-11-15 CV Sciences, Inc. Announces Convertible Note Financing
GlobeNewswire 2021-11-15 CV Sciences, Inc. Reports Third Quarter 2021 Financial Results
GlobeNewswire 2021-11-08 CV Sciences, Inc. to Announce Third Quarter 2021 Results on November 15, 2021
GlobeNewswire 2021-10-07 CV Sciences, Inc. Applauds the California Legislature for Passage of AB 45
GlobeNewswire 2021-08-12 CV Sciences, Inc. Reports Second Quarter 2021 Financial Results
GlobeNewswire 2021-08-05 CV Sciences, Inc. to Announce Second Quarter 2021 Results on August 12, 2021
GlobeNewswire 2021-07-27 CV Sciences, Inc. Receives NutraIngredients-USA 2021 Product of the Year: Immune Support Award
GlobeNewswire 2021-07-26 ATEC Appoints Beth Altman to Board of Directors
GlobeNewswire 2021-07-20 CV Sciences, Inc. and University of California, San Diego Publish Study of Cannabidiol Efficacy in T...
GlobeNewswire 2021-05-13 CV Sciences, Inc. Reports First Quarter 2021 Financial Results
GlobeNewswire 2021-05-11 CV Sciences, Inc. Announces Launch of PlusCBD™ Calm and Sleep Gummies
GlobeNewswire 2021-05-06 CV Sciences, Inc. to Announce First Quarter 2021 Results on May 13, 2021
GlobeNewswire 2021-04-13 CV Sciences and Alkemist Labs Form Partnership to Support the National Institute of Standards and Te...
GlobeNewswire 2021-03-31 Roth Capital Partners Set to Host Upcoming Golden Cannabis Day Event on April 7, 2021
GlobeNewswire 2021-03-18 CV Sciences, Inc. Reports Fiscal Year-End 2020 Financial Results
GlobeNewswire 2021-03-10 CV Sciences, Inc. to Announce Fiscal Year and Fourth Quarter 2020 Results on March 18, 2021
GlobeNewswire 2021-01-05 CV Sciences, Inc. Announces Launch of ProCBD™ Product Line